BlackRock’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

BlackRock’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,368,838	Closed	-$85.1M	–	5452
2023 Q4	$85.1M	Buy	1,368,838 +1,358,838	+13,588%	+$33.8M	﹤0.01%	2167
2023 Q3	$222K	Buy	+10,000	New	+$210K	﹤0.01%	4648

BlackRock's RYZB Position: Q1 2024 in Review

BlackRock sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 1,368,838 shares — an estimated $85.1M sold.

BlackRock first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $85.1M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

BlackRock reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
BlackRock sold 1,368,838 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $85.1M.
BlackRock first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
BlackRock's RayzeBio, Inc. Common Stock position peaked at $85.1M in Q4 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.